Chemical and/or biological therapeutic strategies to ameliorate protein misfolding diseases.

Curr Opin Cell Biol 2011 Apr 9;23(2):231-8. Epub 2010 Dec 9.

Departments of Chemistry and Molecular and Experimental Medicine and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, United States.

Inheriting a mutant misfolding-prone protein that cannot be efficiently folded in a given cell type(s) results in a spectrum of human loss-of-function misfolding diseases. The inability of the biological protein maturation pathways to adapt to a specific misfolding-prone protein also contributes to pathology. Chemical and biological therapeutic strategies are presented that restore protein homeostasis, or proteostasis, either by enhancing the biological capacity of the proteostasis network or through small molecule stabilization of a specific misfolding-prone protein. Herein, we review the recent literature on therapeutic strategies to ameliorate protein misfolding diseases that function through either of these mechanisms, or a combination thereof, and provide our perspective on the promise of alleviating protein misfolding diseases by taking advantage of proteostasis adaptation.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ceb.2010.11.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078197PMC
April 2011
1 Read

Publication Analysis

Top Keywords

misfolding diseases
16
protein misfolding
12
misfolding-prone protein
12
therapeutic strategies
12
protein
8
ameliorate protein
8
specific misfolding-prone
8
strategies ameliorate
8
biological therapeutic
8
homeostasis proteostasis
4
proteostasis network
4
capacity proteostasis
4
proteostasis enhancing
4
biological capacity
4
enhancing biological
4
protein homeostasis
4
strategies presented
4
contributes pathology
4
adapt specific
4
pathways adapt
4

Similar Publications